1. Up front

   Up Front 03 June 2019 Pages: 1105 - 1106

   

2. Type 2 diabetes: a multifaceted disease

   • Ewan R. Pearson

   Review Open access 03 June 2019 Pages: 1107 - 1112

   

3. Neprilysin inhibition: a new therapeutic option for type 2 diabetes?

   • Nathalie Esser
   • Sakeneh Zraika

   Review 14 May 2019 Pages: 1113 - 1122

   

4. Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters

   • Helen R. Murphy

   Commentary Open access 03 June 2019 Pages: 1123 - 1128

5. Cardiorespiratory fitness, muscular strength and risk of type 2 diabetes: a systematic review and meta-analysis

   • Jakob Tarp
   • Andreas P. Støle
   • Anders Grøntved

   Meta-Analysis Open access 23 April 2019 Pages: 1129 - 1142

   

6. Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies

   • Karl Kristensen
   • Linda E. Ögge
   • Kerstin Berntorp

   Article Open access 23 March 2019 Pages: 1143 - 1153

   

7. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease

   • Hiddo J. L. Heerspink
   • Paul Perco
   • Gert Mayer

   Article Open access 17 April 2019 Pages: 1154 - 1166

   

8. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes

   • Nicholas J. Thomas
   • Anita L. Lynam
   • Angus G. Jones

   Short Communication Open access 10 April 2019 Pages: 1167 - 1172

   

9. Perinatal risk factors for type 1 diabetes revisited: a population-based register study

   • Ingeborg Waernbaum
   • Gisela Dahlquist
   • Torbjörn Lind

   Article Open access 30 April 2019 Pages: 1173 - 1184

   

10. Trends in overall, cardiovascular and cancer-related mortality among individuals with diabetes reported on death certificates in the United States between 2007 and 2017

    • Donghee Kim
    • Andrew A. Li
    • Aijaz Ahmed

    Article 22 April 2019 Pages: 1185 - 1194

    

11. The impact of diabetes on productivity in China

    • Thomas R. Hird
    • Ella Zomer
    • Danny Liew

    Article 27 April 2019 Pages: 1195 - 1203

    

12. Genome-wide association study of type 2 diabetes in Africa

    • Ji Chen
    • Meng Sun
    • Ayesha A. Motala

    Article Open access 02 May 2019 Pages: 1204 - 1211

    

13. Glucose controls glucagon secretion by directly modulating cAMP in alpha cells

    • Qian Yu
    • Hongyan Shuai
    • Anders Tengholm

    Article Open access 05 April 2019 Pages: 1212 - 1224

    

14. Vascular endothelial PDPK1 plays a pivotal role in the maintenance of pancreatic beta cell mass and function in adult male mice

    • Atsushi Obata
    • Tomohiko Kimura
    • Hideaki Kaneto

    Article Open access 04 May 2019 Pages: 1225 - 1236

    

15. In vivo imaging of type 1 diabetes immunopathology using eye-transplanted islets in NOD mice

    • Midhat H. Abdulreda
    • R. Damaris Molano
    • Per-Olof Berggren

    Article 14 May 2019 Pages: 1237 - 1250

    

16. Metformin increases endogenous glucose production in non-diabetic individuals and individuals with recent-onset type 2 diabetes

    • Lars C. Gormsen
    • Esben Søndergaard
    • Søren Nielsen

    Short Communication 11 April 2019 Pages: 1251 - 1256

    

17. ApoAI-derived peptide increases glucose tolerance and prevents formation of atherosclerosis in mice

    • Shelley J. Edmunds
    • Rebeca Liébana-García
    • Jens O. Lagerstedt

    Article Open access 08 May 2019 Pages: 1257 - 1267

    

18. Soluble receptor for AGE in diabetic nephropathy and its progression in Finnish individuals with type 1 diabetes

    • Jenny M. Wadén
    • Emma H. Dahlström
    • on behalf of the FinnDiane Study Group

    Article Open access 24 May 2019 Pages: 1268 - 1274

    

19. Bone marrow pericyte dysfunction in individuals with type 2 diabetes

    • Giuseppe Mangialardi
    • David Ferland-McCollough
    • Paolo Madeddu

    Article Open access 17 April 2019 Pages: 1275 - 1290

    

20. Human gut microbiota transferred to germ-free NOD mice modulate the progression towards type 1 diabetes regardless of the pace of beta cell function loss in the donor

    • Vit Neuman
    • Ondrej Cinek
    • Zdenek Sumnik

    Short Communication 25 April 2019 Pages: 1291 - 1296

    

21. Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia

    • Zexu Dang
    • Elisa Avolio
    • Paolo Madeddu

    Article Open access 24 April 2019 Pages: 1297 - 1311

    

22. The Integrated Islet Distribution Program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles

    • Marcela Brissova
    • Joyce C. Niland
    • Carmella Evans-Molina

    Letter 15 May 2019 Pages: 1312 - 1314

    

23. Correction to: Bone marrow pericyte dysfunction in individuals with type 2 diabetes

    • Giuseppe Mangialardi
    • David Ferland-McCollough
    • Paolo Madeddu

    Correction 21 May 2019 Pages: 1315 - 1315